Head and Neck Neuroendocrine Carcinoma — Trials

Head and Neck Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 27
Recruiting: 10
Ph III recruiting: 1
Growth YoY: —
Industry share: 30%
Top sponsor: Eli Lilly and Company
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07661420	211At-MABG in Adults With Advanced Neuroendocrine Cancers	not yet recruiting	Phase 1	16	University of PennsylvaniaOTHER	1	Jun 22, 2026	clinicaltrials
NCT07252661	Study of ACC-1898 in Adult Participants With Advanced Solid Tumors	not yet recruiting	Phase 1	40	AccSalus Biosciences, Inc.INDUSTRY	0	Nov 28, 2025	clinicaltrials